Literature DB >> 11185023

Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit.

C M McBride1, S Halabi, G Bepler, P Lyna, L McIntyre, I Lipkus, J Albright, K O'Briant.   

Abstract

This two-by-two factorially designed study evaluate approaches for communicating feedback of lung cancer susceptibility to smokers as a method for motivating smoking cessation. The study factors were: method of communicating feedback (by mail with telephone follow-up or in-person) and carbon monoxide feedback (yes or no). One-hundred-forty-four smokers were stratified on race and randomized to one of four conditions. Participants were surveyed at baseline and 2-month follow-up. Polymerase chain reaction (PCR) testing for the absence of the glutathione S transferase mu (GSTM1) gene was the susceptibility marker. Regardless of counseling method or carbon monoxide (CO) feedback, the majority (90%) of smokers accurately recalled the test result and 66% accurately interpreted the meaning of the test result. Smokers who received their result in person were significantly less likely to have read the result booklet than those in the telephone counseling group (OR = .28, 95%; CI .12-.62; p < .05). Neither counseling method nor CO feedback increased smokers' perceived risks for lung cancer. However, at the counseling session those who received in-person counseling were significantly less frightened by the test result than those who received telephone counseling (OR = .42, 95%; CI .20-86; p < .05) and at the 2-month follow-up those who received a CO test were significantly less frightened by their susceptibility result (OR = .40, 95%; CI .17-.92; p < .05) than those who did not have a CO test. Evaluation of further refinements in communicating the meaning of susceptibility results to motivate smoking cessation is warranted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11185023     DOI: 10.1080/10810730050131406

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  11 in total

1.  Risk perception and smoking behavior in medically ill smokers: a prospective study.

Authors:  Belinda Borrelli; Rashelle B Hayes; Shira Dunsiger; Joseph L Fava
Journal:  Addiction       Date:  2010-03-22       Impact factor: 6.526

2.  Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.

Authors:  Saskia C Sanderson; Suzanne C O'Neill; Della Brown White; Gerold Bepler; Lori Bastian; Isaac M Lipkus; Colleen M McBride
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

3.  Young smokers' views of genetic susceptibility testing for lung cancer risk: minding unintended consequences.

Authors:  Sharron L Docherty; Colleen M McBride; Saskia C Sanderson; Suzanne C O'Neill; James A Shepperd; Isaac M Lipkus
Journal:  J Community Genet       Date:  2011-09

4.  Immersive virtual environment technology: a promising tool for future social and behavioral genomics research and practice.

Authors:  Susan Persky; Colleen M McBride
Journal:  Health Commun       Date:  2009-12

5.  Biomedical risk assessment as an aid for smoking cessation.

Authors:  Carole Clair; Yolanda Mueller; Jonathan Livingstone-Banks; Bernard Burnand; Jean-Yves Camain; Jacques Cornuz; Myriam Rège-Walther; Kevin Selby; Raphaël Bize
Journal:  Cochrane Database Syst Rev       Date:  2019-03-26

6.  Introducing genetic testing for cardiovascular disease in primary care: a qualitative study.

Authors:  Jo B Middlemass; Momina F Yazdani; Joe Kai; Penelope J Standen; Nadeem Qureshi
Journal:  Br J Gen Pract       Date:  2014-05       Impact factor: 5.386

Review 7.  Public health genomics and genetic test evaluation: the challenge of conducting behavioural research on the utility of lifestyle-genetic tests.

Authors:  Saskia C Sanderson; Jane Wardle; Steve E Humphries
Journal:  J Nutrigenet Nutrigenomics       Date:  2008-08-06

Review 8.  Effectiveness of biomedical risk assessment as an aid for smoking cessation: a systematic review.

Authors:  Raphaël Bize; Bernard Burnand; Yolanda Mueller; Jacques Cornuz
Journal:  Tob Control       Date:  2007-06       Impact factor: 7.552

9.  A surgeon led smoking cessation intervention in a head and neck cancer centre.

Authors:  Ming Wei Tang; Richard Oakley; Catherine Dale; Arnie Purushotham; Henrik Møller; Jennifer Elizabeth Gallagher
Journal:  BMC Health Serv Res       Date:  2014-12-20       Impact factor: 2.655

10.  Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans.

Authors:  Scott Shofer; Matthew Beyea; Sufeng Li; Lori A Bastian; Momen M Wahidi; Michael Kelley; Isaac M Lipkus
Journal:  BMJ Open Respir Res       Date:  2014-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.